A large, multi-institution study led by a Brown University physician-scientist could have important implications for the ...

High in the Ecuadorian Andes, at altitudes thousands of meters above sea level, humans face environmental pressures very ...

PROVIDENCE, R.I. [Brown University] - Interrupting one function of a protein that plays a key role in cell signaling could ...

Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in its Phase I/II clinical trial evaluating ...

Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...

Onctura initiates phase I/II trial of roginolisib in patients with myelofibrosis who are no longer responding to JAK inhibition: Geneva, Switzerland Friday, December 5, 2025, 15: ...

Andean highlanders adapt to thin air through epigenetic gene tuning, revealing a flexible, long-term path to altitude survival.

With both a label expansion and a conversion to a full approval, Eli Lilly has earned the FDA’s go-ahead to act on the ...

Early treatment correlates with better immune fitness, marked by higher CD4-positive naive T cells and a favorable tumor microenvironment. Cilta-cel therapy shows improved outcomes in earlier ...

Researchers profiled a terminally sterilized probiotic-fermented MFH beverage and identified aporphine alkaloids and ...

The full abstracts will be available on the Caris website following the presentations. The Caris Precision Oncology Alliance consists of 98 cancer centers, academic institutions, research consortia ...